EPIC |
BVXP |
Sector |
Pharma and Biotech |
ISIN |
GB00B4QVDF07 |
Market Sector |
AIM |
Market Segment |
ASQ1 |
Main Indices |
FTSE AIM All-Share, FTSE AIM 100 |
Country of register |
Great Britain |
Currency |
British Pound |
Market Cap |
£193.65m |
NMS |
200 |
Shares in issue |
5.22m |
Date Listed |
29-Apr-2014 |
|
2nd Interim |
1st Interim |
Ex-Div |
07-Nov-24 |
11-Apr-24 |
Paid |
21-Nov-24 |
26-Apr-24 |
Amount |
87.00p |
68.00p |
16:24 |
0 @ 3,700.00p |
16:24 |
1 @ 3,700.00p |
15:46 |
12 @ 3,794.00p |
15:23 |
24 @ 3,746.00p |
15:01 |
144 @ 3,794.00p |
CEO |
Peter John Harrison |
Chair |
Ian James Nicholson |
CFO |
Bruce Hiscock |
Top of Page
You are here:
research